106 related articles for article (PubMed ID: 15792872)
41. [Recent advances in facioscapulohumeral muscular dystrophy].
Hayashi YK; Goto K; Nishio I
Rinsho Shinkeigaku; 2012; 52(11):1154-7. PubMed ID: 23196547
[TBL] [Abstract][Full Text] [Related]
42. No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy.
van der Kooi EL; de Greef JC; Wohlgemuth M; Frants RR; van Asseldonk RJ; Blom HJ; van Engelen BG; van der Maarel SM; Padberg GW
Neuromuscul Disord; 2006 Nov; 16(11):766-9. PubMed ID: 17005397
[TBL] [Abstract][Full Text] [Related]
43. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
[TBL] [Abstract][Full Text] [Related]
44. Facioscapulohumeral muscular dystrophy: do neurotrophins play a role?
Angelucci F; Colantoni L
Muscle Nerve; 2010 Jan; 41(1):120-7. PubMed ID: 19813193
[TBL] [Abstract][Full Text] [Related]
45. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients.
Davidovic L; Sacconi S; Bechara EG; Delplace S; Allegra M; Desnuelle C; Bardoni B
J Med Genet; 2008 Oct; 45(10):679-85. PubMed ID: 18628314
[TBL] [Abstract][Full Text] [Related]
46. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
[TBL] [Abstract][Full Text] [Related]
47. Genes on bovine chromosome 18 associated with bilateral convergent strabismus with exophthalmos in German Brown cattle.
Fink S; Mömke S; Wöhlke A; Distl O
Mol Vis; 2008 Sep; 14():1737-51. PubMed ID: 18836565
[TBL] [Abstract][Full Text] [Related]
48. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
[TBL] [Abstract][Full Text] [Related]
49. [Facioscapulohumeral muscular dystrophy].
Wilbers J; Frants RR; van Engelen BG; Padberg GW; van der Maarel SM
Ned Tijdschr Tandheelkd; 2010 Jan; 117(1):11-4. PubMed ID: 20180344
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic challenges in facioscapulohumeral muscular dystrophy.
Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C
Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574
[TBL] [Abstract][Full Text] [Related]
51. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451
[TBL] [Abstract][Full Text] [Related]
52. Becker's muscular dystrophy aggravating facioscapulohumeral muscular dystrophy--double trouble as an explanation for an atypical phenotype.
Rudnik-Schöneborn S; Weis J; Kress W; Häusler M; Zerres K
Neuromuscul Disord; 2008 Nov; 18(11):881-5. PubMed ID: 18684626
[TBL] [Abstract][Full Text] [Related]
53. Activation of both acfA and acfD transcription by Vibrio cholerae ToxT requires binding to two centrally located DNA sites in an inverted repeat conformation.
Withey JH; DiRita VJ
Mol Microbiol; 2005 May; 56(4):1062-77. PubMed ID: 15853890
[TBL] [Abstract][Full Text] [Related]
54. Characterization of human collagen XVIII promoter 2: interaction of Sp1, Sp3 and YY1 with the regulatory region and a SNP that increases transcription in hepatocytes.
Armelin-Correa LM; Lin CJ; Barbosa A; Bagatini K; Winnischofer SM; Sogayar MC; Passos-Bueno MR
Matrix Biol; 2005 Dec; 24(8):550-9. PubMed ID: 16229994
[TBL] [Abstract][Full Text] [Related]
55. GABP, HCF-1 and YY1 are involved in Rb gene expression during myogenesis.
Deléhouzée S; Yoshikawa T; Sawa C; Sawada J; Ito T; Omori M; Wada T; Yamaguchi Y; Kabe Y; Handa H
Genes Cells; 2005 Jul; 10(7):717-31. PubMed ID: 15966902
[TBL] [Abstract][Full Text] [Related]
56. Nucleophosmin/B23 regulates PCNA promoter through YY1.
Weng JJ; Yung BY
Biochem Biophys Res Commun; 2005 Sep; 335(3):826-31. PubMed ID: 16099430
[TBL] [Abstract][Full Text] [Related]
57. Characterization of the canine CLCN3 gene and evaluation as candidate for late-onset NCL.
Wohlke A; Distl O; Drogemuller C
BMC Genet; 2006 Mar; 7():13. PubMed ID: 16515703
[TBL] [Abstract][Full Text] [Related]
58. CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions.
Crawford EL; Blomquist T; Mullins DN; Yoon Y; Hernandez DR; Al-Bagdhadi M; Ruiz J; Hammersley J; Willey JC
Carcinogenesis; 2007 Dec; 28(12):2552-9. PubMed ID: 17893230
[TBL] [Abstract][Full Text] [Related]
59. [Facioscapuloperoneal muscular dystrophy: correlation between a phenotype and genotype].
Rudenko DI; Kazakov BM; Skoromets AA; Magomedova NK
Patol Fiziol Eksp Ter; 2009; (2):22-7. PubMed ID: 19537084
[TBL] [Abstract][Full Text] [Related]
60. Atypical facet of Möbius syndrome: association with facioscapulohumeral muscular dystrophy.
Kolski HK; Leonard NJ; Lemmers RJ; Bamforth JS
Muscle Nerve; 2008 Apr; 37(4):526-9. PubMed ID: 18059038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
